Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The Rand Corporation is reporting that, in 2022, employers and private insurers paid hospitals an average 254% more than what Medicare would have spent for the same services in the same facilities.
Around the world, 3 of 4 workers who routinely handle information are now using generative AI on the job. And almost half of them are new to the technology, having begun using it only over the past half-year.
Four of five hospital leaders trust the accuracy of their institution’s data. Yet almost half of useable data gets underutilized if not completely untapped for guiding business and clinical decisions.
Hospital employment models, reimbursement policies and private equity have all led to a massive reduction in the number of cardiologists working for a private practice, ACC President Cathie Biga, MSN, told Cardiovascular Business.
As AI continues infiltrating healthcare at nearly every level, the technology’s potential for good and ill must become—or remain—a preeminent concern for hospital boards of trustees.
It’s not easy to get patients, providers, payers, vendors and regulators to agree on any one aspect of healthcare delivery. But the CDRH recently managed to get everyone to settle on a working definition of transparency.
Members of C-suites around the world are making room for a new teammate: the CAIO. In healthcare, some organizations are hiring for the even more specialized position of CHAIO, for chief health AI officer.
Along with the obvious hits to patient traffic and population health, the COVID-19 pandemic delivered a financial upending to U.S. healthcare. Is it over yet?
The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible.
Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.